Gray Kueberuwa

CEO at Immunokey

Presenter

Dr Gray Kueberuwa is Chief Executive Officer and Co-Founder of ImmunoKey, a UK biotechnology company developing next-generation CAR-T cell therapies for solid tumours. He has experience across the cell-therapy development pathway, including discovery research, intellectual property, process development, GMP manufacturing, regulatory engagement and clinical operations. Previously, he held leadership roles in a cell-therapy company that progressed through acquisition, international expansion and public-market financing. At ImmunoKey, he leads corporate strategy, fundraising, partnerships and the development of the company’s multi-antigen, dual-receptor CAR-T platform, with an initial focus on ovarian cancer.